Global Noninvasive Cancer Diagnostics Market Insights and Forecast to 2028

Report ID: 1804106 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Clinical Chemistry
        1.2.3 Immunochemistry/Immunoassay
        1.2.4 Molecular Diagnostics
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Solid Tumors
        1.3.3 Blood Cancer
        1.3.4 Lung Cancer
        1.3.5 Breast Cancer
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Noninvasive Cancer Diagnostics Market Perspective (2017-2028)
    2.2 Noninvasive Cancer Diagnostics Growth Trends by Region
        2.2.1 Noninvasive Cancer Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Noninvasive Cancer Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Noninvasive Cancer Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Noninvasive Cancer Diagnostics Market Dynamics
        2.3.1 Noninvasive Cancer Diagnostics Industry Trends
        2.3.2 Noninvasive Cancer Diagnostics Market Drivers
        2.3.3 Noninvasive Cancer Diagnostics Market Challenges
        2.3.4 Noninvasive Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Noninvasive Cancer Diagnostics Players by Revenue
        3.1.1 Global Top Noninvasive Cancer Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Noninvasive Cancer Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Noninvasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Noninvasive Cancer Diagnostics Revenue
    3.4 Global Noninvasive Cancer Diagnostics Market Concentration Ratio
        3.4.1 Global Noninvasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Noninvasive Cancer Diagnostics Revenue in 2021
    3.5 Noninvasive Cancer Diagnostics Key Players Head office and Area Served
    3.6 Key Players Noninvasive Cancer Diagnostics Product Solution and Service
    3.7 Date of Enter into Noninvasive Cancer Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Noninvasive Cancer Diagnostics Breakdown Data by Type
    4.1 Global Noninvasive Cancer Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Noninvasive Cancer Diagnostics Forecasted Market Size by Type (2023-2028)
5 Noninvasive Cancer Diagnostics Breakdown Data by Application
    5.1 Global Noninvasive Cancer Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Noninvasive Cancer Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Noninvasive Cancer Diagnostics Market Size (2017-2028)
    6.2 North America Noninvasive Cancer Diagnostics Market Size by Type
        6.2.1 North America Noninvasive Cancer Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Noninvasive Cancer Diagnostics Market Size by Type (2023-2028)
        6.2.3 North America Noninvasive Cancer Diagnostics Market Share by Type (2017-2028)
    6.3 North America Noninvasive Cancer Diagnostics Market Size by Application
        6.3.1 North America Noninvasive Cancer Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Noninvasive Cancer Diagnostics Market Size by Application (2023-2028)
        6.3.3 North America Noninvasive Cancer Diagnostics Market Share by Application (2017-2028)
    6.4 North America Noninvasive Cancer Diagnostics Market Size by Country
        6.4.1 North America Noninvasive Cancer Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Noninvasive Cancer Diagnostics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Noninvasive Cancer Diagnostics Market Size (2017-2028)
    7.2 Europe Noninvasive Cancer Diagnostics Market Size by Type
        7.2.1 Europe Noninvasive Cancer Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Noninvasive Cancer Diagnostics Market Size by Type (2023-2028)
        7.2.3 Europe Noninvasive Cancer Diagnostics Market Share by Type (2017-2028)
    7.3 Europe Noninvasive Cancer Diagnostics Market Size by Application
        7.3.1 Europe Noninvasive Cancer Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Noninvasive Cancer Diagnostics Market Size by Application (2023-2028)
        7.3.3 Europe Noninvasive Cancer Diagnostics Market Share by Application (2017-2028)
    7.4 Europe Noninvasive Cancer Diagnostics Market Size by Country
        7.4.1 Europe Noninvasive Cancer Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Noninvasive Cancer Diagnostics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Noninvasive Cancer Diagnostics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Noninvasive Cancer Diagnostics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Noninvasive Cancer Diagnostics Market Size (2017-2028)
    9.2 Latin America Noninvasive Cancer Diagnostics Market Size by Type
        9.2.1 Latin America Noninvasive Cancer Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Noninvasive Cancer Diagnostics Market Size by Type (2023-2028)
        9.2.3 Latin America Noninvasive Cancer Diagnostics Market Share by Type (2017-2028)
    9.3 Latin America Noninvasive Cancer Diagnostics Market Size by Application
        9.3.1 Latin America Noninvasive Cancer Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Noninvasive Cancer Diagnostics Market Size by Application (2023-2028)
        9.3.3 Latin America Noninvasive Cancer Diagnostics Market Share by Application (2017-2028)
    9.4 Latin America Noninvasive Cancer Diagnostics Market Size by Country
        9.4.1 Latin America Noninvasive Cancer Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Noninvasive Cancer Diagnostics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Noninvasive Cancer Diagnostics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Noninvasive Cancer Diagnostics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Noninvasive Cancer Diagnostics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Precision Therapeutics, Inc. (U.S.)
        11.1.1 Precision Therapeutics, Inc. (U.S.) Company Details
        11.1.2 Precision Therapeutics, Inc. (U.S.) Business Overview
        11.1.3 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
        11.1.4 Precision Therapeutics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022)
        11.1.5 Precision Therapeutics, Inc. (U.S.) Recent Developments
    11.2 A&G Pharmaceutical, Inc. (U.S.)
        11.2.1 A&G Pharmaceutical, Inc. (U.S.) Company Details
        11.2.2 A&G Pharmaceutical, Inc. (U.S.) Business Overview
        11.2.3 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
        11.2.4 A&G Pharmaceutical, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022)
        11.2.5 A&G Pharmaceutical, Inc. (U.S.) Recent Developments
    11.3 Affymetrix Inc. (U.S.)
        11.3.1 Affymetrix Inc. (U.S.) Company Details
        11.3.2 Affymetrix Inc. (U.S.) Business Overview
        11.3.3 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
        11.3.4 Affymetrix Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022)
        11.3.5 Affymetrix Inc. (U.S.) Recent Developments
    11.4 AVIVA Biosciences Corporation (U.S.)
        11.4.1 AVIVA Biosciences Corporation (U.S.) Company Details
        11.4.2 AVIVA Biosciences Corporation (U.S.) Business Overview
        11.4.3 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Introduction
        11.4.4 AVIVA Biosciences Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022)
        11.4.5 AVIVA Biosciences Corporation (U.S.) Recent Developments
    11.5 BIOVIEW Inc. (U.S.)
        11.5.1 BIOVIEW Inc. (U.S.) Company Details
        11.5.2 BIOVIEW Inc. (U.S.) Business Overview
        11.5.3 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
        11.5.4 BIOVIEW Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022)
        11.5.5 BIOVIEW Inc. (U.S.) Recent Developments
    11.6 Laboratory Corporation of America Holdings (LabCorp) (U.S.)
        11.6.1 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
        11.6.2 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Business Overview
        11.6.3 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Introduction
        11.6.4 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022)
        11.6.5 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Developments
    11.7 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
        11.7.1 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
        11.7.2 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Business Overview
        11.7.3 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
        11.7.4 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022)
        11.7.5 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Developments
    11.8 Digene Corporation (U.S.)
        11.8.1 Digene Corporation (U.S.) Company Details
        11.8.2 Digene Corporation (U.S.) Business Overview
        11.8.3 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Introduction
        11.8.4 Digene Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022)
        11.8.5 Digene Corporation (U.S.) Recent Developments
    11.9 Gen-Probe Incorporated (U.S.)
        11.9.1 Gen-Probe Incorporated (U.S.) Company Details
        11.9.2 Gen-Probe Incorporated (U.S.) Business Overview
        11.9.3 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Introduction
        11.9.4 Gen-Probe Incorporated (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022)
        11.9.5 Gen-Probe Incorporated (U.S.) Recent Developments
    11.10 IVDiagnostics, Inc. (U.S.)
        11.10.1 IVDiagnostics, Inc. (U.S.) Company Details
        11.10.2 IVDiagnostics, Inc. (U.S.) Business Overview
        11.10.3 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
        11.10.4 IVDiagnostics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022)
        11.10.5 IVDiagnostics, Inc. (U.S.) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Clinical Chemistry
    Table 3. Key Players of Immunochemistry/Immunoassay
    Table 4. Key Players of Molecular Diagnostics
    Table 5. Key Players of Others
    Table 6. Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Noninvasive Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Noninvasive Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Noninvasive Cancer Diagnostics Market Share by Region (2017-2022)
    Table 10. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Noninvasive Cancer Diagnostics Market Share by Region (2023-2028)
    Table 12. Noninvasive Cancer Diagnostics Market Trends
    Table 13. Noninvasive Cancer Diagnostics Market Drivers
    Table 14. Noninvasive Cancer Diagnostics Market Challenges
    Table 15. Noninvasive Cancer Diagnostics Market Restraints
    Table 16. Global Noninvasive Cancer Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Noninvasive Cancer Diagnostics Revenue Share by Players (2017-2022)
    Table 18. Global Top Noninvasive Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Cancer Diagnostics as of 2021)
    Table 19. Ranking of Global Top Noninvasive Cancer Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Noninvasive Cancer Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Noninvasive Cancer Diagnostics Product Solution and Service
    Table 23. Date of Enter into Noninvasive Cancer Diagnostics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2017-2022)
    Table 27. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Noninvasive Cancer Diagnostics Revenue Market Share by Type (2023-2028)
    Table 29. Global Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Noninvasive Cancer Diagnostics Revenue Share by Application (2017-2022)
    Table 31. Global Noninvasive Cancer Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Noninvasive Cancer Diagnostics Revenue Share by Application (2023-2028)
    Table 33. North America Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Noninvasive Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Noninvasive Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Noninvasive Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Noninvasive Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Noninvasive Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Noninvasive Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Noninvasive Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Noninvasive Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Noninvasive Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Noninvasive Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Noninvasive Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Noninvasive Cancer Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Noninvasive Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Noninvasive Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Noninvasive Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Noninvasive Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Noninvasive Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Noninvasive Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Noninvasive Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Noninvasive Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Noninvasive Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Noninvasive Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Precision Therapeutics, Inc. (U.S.) Company Details
    Table 64. Precision Therapeutics, Inc. (U.S.) Business Overview
    Table 65. Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
    Table 66. Precision Therapeutics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 67. Precision Therapeutics, Inc. (U.S.) Recent Developments
    Table 68. A&G Pharmaceutical, Inc. (U.S.) Company Details
    Table 69. A&G Pharmaceutical, Inc. (U.S.) Business Overview
    Table 70. A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
    Table 71. A&G Pharmaceutical, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 72. A&G Pharmaceutical, Inc. (U.S.) Recent Developments
    Table 73. Affymetrix Inc. (U.S.) Company Details
    Table 74. Affymetrix Inc. (U.S.) Business Overview
    Table 75. Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Product
    Table 76. Affymetrix Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 77. Affymetrix Inc. (U.S.) Recent Developments
    Table 78. AVIVA Biosciences Corporation (U.S.) Company Details
    Table 79. AVIVA Biosciences Corporation (U.S.) Business Overview
    Table 80. AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Product
    Table 81. AVIVA Biosciences Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 82. AVIVA Biosciences Corporation (U.S.) Recent Developments
    Table 83. BIOVIEW Inc. (U.S.) Company Details
    Table 84. BIOVIEW Inc. (U.S.) Business Overview
    Table 85. BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Product
    Table 86. BIOVIEW Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 87. BIOVIEW Inc. (U.S.) Recent Developments
    Table 88. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
    Table 89. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Business Overview
    Table 90. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Product
    Table 91. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 92. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Developments
    Table 93. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
    Table 94. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Business Overview
    Table 95. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Product
    Table 96. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 97. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Developments
    Table 98. Digene Corporation (U.S.) Company Details
    Table 99. Digene Corporation (U.S.) Business Overview
    Table 100. Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Product
    Table 101. Digene Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 102. Digene Corporation (U.S.) Recent Developments
    Table 103. Gen-Probe Incorporated (U.S.) Company Details
    Table 104. Gen-Probe Incorporated (U.S.) Business Overview
    Table 105. Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Product
    Table 106. Gen-Probe Incorporated (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 107. Gen-Probe Incorporated (U.S.) Recent Developments
    Table 108. IVDiagnostics, Inc. (U.S.) Company Details
    Table 109. IVDiagnostics, Inc. (U.S.) Business Overview
    Table 110. IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
    Table 111. IVDiagnostics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 112. IVDiagnostics, Inc. (U.S.) Recent Developments
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Noninvasive Cancer Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Clinical Chemistry Features
    Figure 3. Immunochemistry/Immunoassay Features
    Figure 4. Molecular Diagnostics Features
    Figure 5. Others Features
    Figure 6. Global Noninvasive Cancer Diagnostics Market Share by Application: 2021 VS 2028
    Figure 7. Solid Tumors Case Studies
    Figure 8. Blood Cancer Case Studies
    Figure 9. Lung Cancer Case Studies
    Figure 10. Breast Cancer Case Studies
    Figure 11. Others Case Studies
    Figure 12. Noninvasive Cancer Diagnostics Report Years Considered
    Figure 13. Global Noninvasive Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Noninvasive Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Noninvasive Cancer Diagnostics Market Share by Region: 2021 VS 2028
    Figure 16. Global Noninvasive Cancer Diagnostics Market Share by Players in 2021
    Figure 17. Global Top Noninvasive Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Cancer Diagnostics as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Noninvasive Cancer Diagnostics Revenue in 2021
    Figure 19. North America Noninvasive Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 21. North America Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 22. North America Noninvasive Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 23. United States Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Noninvasive Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Noninvasive Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 29. Germany Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Noninvasive Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Noninvasive Cancer Diagnostics Market Size Share by Region (2017-2028)
    Figure 39. China Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Noninvasive Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Noninvasive Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 49. Mexico Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Noninvasive Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Noninvasive Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Noninvasive Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Noninvasive Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 55. Turkey Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Noninvasive Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Precision Therapeutics, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2017-2022)
    Figure 59. A&G Pharmaceutical, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2017-2022)
    Figure 60. Affymetrix Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2017-2022)
    Figure 61. AVIVA Biosciences Corporation (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2017-2022)
    Figure 62. BIOVIEW Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2017-2022)
    Figure 63. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2017-2022)
    Figure 64. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2017-2022)
    Figure 65. Digene Corporation (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2017-2022)
    Figure 66. Gen-Probe Incorporated (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2017-2022)
    Figure 67. IVDiagnostics, Inc. (U.S.) Revenue Growth Rate in Noninvasive Cancer Diagnostics Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Precision Therapeutics, Inc. (U.S.)
A&G Pharmaceutical, Inc. (U.S.)
Affymetrix Inc. (U.S.)
AVIVA Biosciences Corporation (U.S.)
BIOVIEW Inc. (U.S.)
Laboratory Corporation of America Holdings (LabCorp) (U.S.)
Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
Digene Corporation (U.S.)
Gen-Probe Incorporated (U.S.)
IVDiagnostics, Inc. (U.S.)
Frequently Asked Questions
Noninvasive Cancer Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Noninvasive Cancer Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Noninvasive Cancer Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Therapeutic Stents

Therapeutic Stents market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Terminal Boxes

Terminal Boxes market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More